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Hybrid Shell Engineering of Animal Cells for Immune
Protections and Regulation of Drug Delivery: Towards
the Design of ‘‘Artificial Organs’’
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Abstract
Background: With the progress in medicine, the average human life expectancy is continuously increasing. At the same
time, the number of patients who require full organ transplantations is augmenting. Consequently, new strategies for cell
transplantation are the subject of great interest.
Methodology/Principal Findings: This work reports the design, the synthesis and the characterisation of robust and
biocompatible mineralised beads composed of two layers: an alginate-silica composite core and a Ca-alginate layer. The
adequate choice of materials was achieved through cytotoxicity LDH release measurement and in vitro inflammatory assay
(IL-8) to meet the biocompatibility requirements for medical purpose. The results obtained following this strategy provide a
direct proof of the total innocuity of silica and alginate networks for human cells as underscored by the non-activation of
immune defenders (THP-1 monocytes). The accessible pore size diameter of the mineralised beads synthesized was
estimated between 22 and 30 nm, as required for efficient immuno-isolation without preventing the diffusion of nutrients
and metabolites. The model human cells, HepG2, entrapped within these hybrid beads display a high survival rate over
more than six weeks according to the measurements of intracellular enzymatic activity, respiration rate, as well as the ‘‘de
novo’’ biosynthesis and secretion of albumin out of the beads.
Conclusions/Significance: The current study shows that active mammalian cells can be protected by a silica-alginate hybrid
shell-like system. The functionality of the cell strain can be maintained. Consequently, cells coated with an artificial and a
biocompatible mineral shell could respond physiologically within the human body in order to deliver therapeutic agents in
a controlled fashion (i.e. insulin), substituting the declining organ functions of the patient.
Citation: Dandoy P, Meunier CF, Michiels C, Su B-L (2011) Hybrid Shell Engineering of Animal Cells for Immune Protections and Regulation of Drug Delivery:
Towards the Design of ‘‘Artificial Organs’’. PLoS ONE 6(6): e20983. doi:10.1371/journal.pone.0020983
Editor: Richard Haverkamp, Massey University, New Zealand
Received April 19, 2011; Accepted May 14, 2011; Published June 22, 2011
Copyright:  2011 Dandoy et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Belgian FNRS (Fonds de la Recherche Scientifique - FNRS) http://www1.frs-fnrs.be/. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: bao-lian.su@fundp.ac.be (B-LS); christophe.meunier@fundp.ac.be (CFM)
Introduction
Since the original idea published in 1933 by Bisceglie [1],
significant advances have been achieved to develop immuno-
isolation methods for long-term transplantation of xenogenic cells
or tissues. The final aim of this technology is to treat human
disorders such as protein or hormone deficiencies (e.g. type 1
diabetes mellitus, factor IX of hemophilia B, Parkinson’s disease or
Alzheimer’s disease) [2–5], overcoming the usual obstacles of
limited supply of donor tissue or replacing the conventional drug
treatments.
Generally speaking, immuno-isolation should be understood as a
way to protect cells against mechanical stress and rejection from the
immune system of the host body while allowing the diffusion
of nutrients, oxygen and metabolites. Conceptually, they are
separated by a biocompatible and semi-permeable membrane.
The porosity of this cell-entrapping material is a key parameter for
successful immuno-isolation. From the literature, the targeted pore
size is still not clear. If a molecular weight (MW) cut-off of around
150 kDa is generally accepted [6,7], which is the MW of the
immunoglobulin G (IgG), the diameter related to this value is still
debated. Nevertheless, a pore size between 5 to 20 nm is often
referenced [8–10]. Apart from porosity issues, the robustness and
the biocompatibility of the semi-permeable system are also
important features for the successful transplantation of cells. The
long-term efficiency of this technology is not only dependent on the
final properties of the synthesised materials, but is also closely linked
to the biocompatibility of the material precursors and contaminants,
the synthesis pathway, as well as the ageing phase of the material.
Finally, the shape and size of the system play a critical role to avoid
hypoxia-induced cell death. Microencapsulation, where a small
number of cells are entrapped into several microspheres, is preferred
than macroencapsulation, where huge amounts of cells are
entrapped in a single immuno-isolating membrane [11]. In fact,
the microencapsulation approach provides a way to enhance
diffusion by increasing the surface area/volume ratio.
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Advances in chemical synthesis have enabled the development
of various types of materials as potential candidates for entrapping
fragile animal cells. During the past decade, biopolymers (e.g.
alginate, alginate/Poly-L-Lysine, chitosan, collagen), organic
hydrogels (e.g. polyvinylalcohol, polyethylene glycol) or inorganic
oxide gels (e.g. silica) have been employed to develop a wide range
of medical applications [12–15]. While purified alginate is
nowadays the most employed and recognized biocompatible
material for cell encapsulation technology [16], it suffers from a
poor mechanical stability and swells with time. To overcome this
problem, the alginate core has been coated by different polycations
such as poly-L-lysine, poly-L-ornithine, polyethyleneimine, poly-
allylamine or chitosan. However, these positively charged
polymers (under physiological conditions) have been reported to
be toxic since they can induce inflammatory reaction and cell
necrosis [17,18]. In this context, association of alginate capsules
with biocompatible silica species brings great opportunities and
interests as it allows the combination of soft biocompatible
component (viz. alginate) with a resistant and non swelling
component (viz. silica) [19]. In fact, the mineralisation of
biopolymers by silica can be used to improve their chemical and
mechanical performances. In the field of animal cell encapsulation,
Carturan et al. [20,21] and Sakai et al. [22–24] independently
reported two methods to design alginate-silica capsules. Never-
theless, until now, the silica is only deposited at the polymer
surface (layer of few microns) and not within the alginate beads.
Consequently, the mechanical resistance of these capsules is not
optimal and could still be improved since the slow but inevitable
dissolution of SiO2 occurs in the body fluids [25].
In this paper, novel biocompatible ceramic-like beads have
been synthesised under mild conditions via a rapid and simple
approach. The material precursors were rationally selected on the
basis of cytotoxicity and immune tests. The mineralised beads
have been made with two layers (alginate-silica composite/Ca-
alginate) to ensure an excellent mechanical stability and a total
biocompatibility over time. Besides, small spherical beads, rather
than hybrid matrix, have been targeted to promote the diffusion
of nutrients and metabolites. The properties of this hybrid
material are investigated to explore the opportunity to develop an
‘‘artificial organ’’. For instance, the entrapment of b-cells (or
pancreatic islets) within such kind of materials could be used for
the treatment of Diabetes mellitus thanks to the in vivo production of
insulin required by the organism to maintain glucose homeostasis.
In the present study, human hepatocellular carcinoma cell line
(HepG2) was chosen as a cell model because pancreatic b-cells
cannot be easily cultivated [26,27]. These HepG2 cells have
similar size and morphology compared to those of b-cells.
Additionally HepG2 cells continuously secrete albumin and could
thus be used to mimic the diffusion of insulin out of the newly
formed material.
Results and Discussion
Design of a robust and biocompatible host material
The immobilisation of animal cells in a robust and biocompat-
ible material is the challenge for the successful development of cell
therapy. Among the vast number of materials, porous silica is
promising. This transparent inorganic material is essentially
chemically inert, thermally stable and mechanically strong. Even
though silica is generally considered as a biocompatible material
and used in medical applications, several reports suggest that it is a
strong macrophage-attracting substance [28]. In fact, the cyto-
compatibility of the final material is closely connected to its
synthesis pathway. For instance, the shape and size of silica
particles formed during the encapsulation procedure can affect the
cell integrity and hence trigger inflammation. Besides, it is well
recognised that the interaction of silica nanoparticles with animal
cells can induce oxidative stresses, cell membrane damages and
possibly cell apoptosis/necrosis [29].
Generally, silica gels are obtained under mild conditions via the
hydrolysis and condensation of alkoxysilanes (e.g. TMOS, TEOS).
A major drawback of this pathway is the release of cytotoxic by-
products (e.g. methanol, ethanol). It is well-known that short chain
alcohol can affect biological membranes [30] or even destroy
them. Therefore, alternative protocols have been reported such as
an intermediate distillation step of the silica sol to remove most of
alcohols prior to the introduction of the living cells [31]. Another
strategy is based on the utilisation of organically modified
precursors that liberate non- or less-toxic polyols (e.g. ethylene
glycol, glycerol) [32–35]. Besides, Livage et al. reported the
synthesis of porous silica structures by an acidification of diluted
sodium silicate solutions [36]. This method, called aqueous route,
has been used to efficiently entrap heterotrophic or photoauto-
trophic bacteria [37,38]. Nevertheless, a negative aspect of this
protocol is the excess of sodium ions that can disturb the cellular
osmotic balance. In fact, this pathway was reported to be
unsuitable to entrap fragile biological structures such as photo-
synthetically active organelles [39] and plant cells [40,41].
Before performing HepG2 cell encapsulation, a cytotoxicity
test was thus firstly accomplished to estimate the lethal dose of the
by-products (upper limit concentration) that are formed during
the different preparation methods described above. Figure 1
presents the results for the cytotoxicity test. The control is the
reference; it represents the natural death of cells occurring during
the experiment. For a value higher than 6.6(62.4) %, the
concentration of the tested compounds is considered to be toxic.
As shown in Figure 1, ethanol was toxic at concentration between
100 mM and 1000 mM. On the contrary, the effects of methanol
strongly depended on its concentration. At low concentration
(below 250 mM), methanol can be considered as a non-toxic
agent. However, the percentage of dead cells increased up to 40%
when they were exposed to 1000 mM of methanol. Polyols such
as glycerol were also significantly cytotoxic at every concentration
tested, but the percentage of cells dead was lower at high
concentration compared to the other aliphatic mono-alcohols.
That is why it is often used as a cryoprotectant for the storage of
cultured cells (at 2196uC, its toxicity falls dramatically). Finally,
the toxicity of sodium chloride was also measured to evaluate the
relevance of gels obtained via an aqueous route. The data
highlight that NaCl is not detrimental for the cells below a
concentration of 500 mM. These results suggest that HepG2
could be entrapped within silica gel formed via the aqueous route
(Na2SiO3 as silica precursor). This hypothesis was strengthened
by the complete innocuity of aggregated silica nanoparticles
(Figure 1). Nevertheless, in conventional encapsulation proce-
dures, the introduction of silica precursors within the buffered
culture medium exposes the cells to unnatural and brutal
variations of their environment during the host-material synthe-
sis. Therefore, the chemical conditions of sol-gel synthesis could
be considered as harmful for human cells such as HepG2 cells.
Recently, Bilmes et al. demonstrated that the pre-encapsulation of
cells within an alginate capsule is beneficial to protect yeasts from
silica precursors (e.g. sodium silicate). They showed that low
concentrations of sodium alginate did not provide efficient
protection to immobilised cells and too high concentrations
generated ionic stress. But for alginate concentrations between
1% and 2%, the stress levels of cells were significantly lower that
observed in cells directly exposed to silica precursors [42]. Based
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on these results, a three-step approach has been used here to
encapsulate living animal cells within biocompatible hybrid
alginate-silica beads.
In order to confirm the biocompatibility of the building blocks
used to synthesise the ceramic-like beads, an in vitro test for the
detection of immune response was secondly performed. The
objective was to determine if silica nanopowders or sodium
alginate can activate immune defenders (THP-1 monocytes) to
start a ‘‘rejection’’ mechanism. Secretion of inflammatory cytokine
(IL-8) was thus assayed as a measure of macrophage activation.
Before the experiment, sodium alginate (anionic polysaccharide
composed of guluronic and mannuronic units) was purified to
improve its biocompatibility since all the contaminants (e.g.
endotoxins, proteins, polyphenols) sequestered in this crude
powder are known to be toxic for animal cells [43]. Figure 2
shows the level of IL-8 secreted by THP-1 monocytes in contact
with alginate or silica materials (Table 1). Without any cell (C, CA
and CS), IL-8 was not detected (Figure 2a). However, it has to be
mentioned that HepG2 cells constitutively secrete IL-8 (CH in
Figure 2a). The presence of the alginate polymers or silica particles
did not affect them as shown by steady state IL-8 concentration
(CHA, CHS in Figure 2a). When THP-1 monocytes were put in
contact with the materials (A, AH, S, SH in Figure 2b), the IL-8
concentration detected in the supernatants was not higher
compared to CA, CHA, CS or CHS samples. These observations
confirm the total biocompatibility and the inertness of purified
alginate and of silica material.
The next section described the characterisation of robust and
biocompatible mineralised beads composed of two layers: an
alginate-silica composite core and a Ca-alginate layer. This bead
was mineralised with silica to strengthen the polysaccharide
beads. Since in vivo biocompatibility data have only been
described in the literature for alginate, an outer layer of alginate
was deposited at the surface to mask the possible unwanted
interactions [44]. The performance of these novel beads was
compared to conventional alginate capsules in term of long-term
stability and cell viability.
Material characterizations
Alginate capsules and silica mineralised beads were studied to
determine their properties, especially regarding their porosity
which is a key parameter that determines the diffusion of chemicals
Figure 1. Concentration-dependent effects of different sol-gel by-products on HepG2 cells after 5 hours of incubation. The
membrane damaging effect of chemicals was quantified by measuring the release of the cytosolic enzyme LDH. Results are presented in percentage
of cytotoxicity as means 6 1 S.D. (n = 3).
doi:10.1371/journal.pone.0020983.g001
Figure 2. In vitro determination of a proinflammatory response
due to alginate or silica around cells. Proinflammatory response is
highlighted by IL-8, which is secreted by monocytes THP-1 (immune
defenders) when they are activated. The control (a) are made without
THP-1 to underline the basal concentration of IL-8 produced by HepG2
cells. Results are presented as means 6 1 S.D. (n = 3).
doi:10.1371/journal.pone.0020983.g002
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including nutrients required for cell survival. After being super-
critically dried with liquid carbon dioxide to preserve the porous
network by avoiding the collapse of pores through capillary action,
the obtained aerogels were characterised by nitrogen adsorption-
desorption measurements and scanning electron microscopy (SEM).
In all cases, analysis of the textural properties of materials shows a
type II isotherm according to the IUPAC classification systems. The
surface area of mineralised beads was very high (414 m2.g21)
compared to alginate capsules (Figure 3). This increase in surface
area may suggest an efficient mineralisation of the polymeric beads
and a great improvement of their mechanical properties. As a
matter of fact, SEM micrographs emphasize that hybrid alginate-
silica beads are more robust compared to alginate capsules. After 50
days of incubation, the alginate capsules swelled and became very
fragile. Typically, large cracks (50 mm in some parts) appeared at the
surface of the polymeric capsules (Figure 4a and b) while the
mineralised beads presented intact surface morphology (Figure 4c
and d). Besides, the core of the mineralised beads was characterised
by a dense porous network that strengthens the overall mechanical
properties of the material (Figure 5a, b and c). EDX analysis
suggests that the three-dimensional structure of the bead core was
formed via the deposition of silica (Figure 5d). In order to confirm
this hypothesis, a silica tracer was used. PDMPO is an excellent
fluorescent probe for imaging newly deposited silica [45]. For that
purpose, hydrated alginate-silica beads and alginate capsules (50
days old) were incubated with this probe and observed with an
optical microscope under an UV-excitation light. As shown by
Figure 6a and b, no trace of silica species was observed within
optically transparent alginate capsule. Conversely, the whole
mineralised beads (Figure 6e) as well as every cross-section of the
material (Figure 6c) displayed an intense blue fluorescence
(Figure 6d and f). These observations indicate that silica was
homogeneously distributed throughout the beads. Although, silica
and alginate were both negatively charged at physiological pH,
silica species can diffuse within the freshly formed alginate capsules.
Since buffered culture medium present in the core part of the beads
maintains the pH near 7, its favours the catalysis of silica
condensation. It is assumed that the presence of weak hydrogen
bonding interactions between alginate and the silanol groups
promotes the formation of uniform hybrid alginate-silica composites
[46,47].
The immuno-isolation efficiency was investigated by studying the
entrance of fluorescent molecules of known diameters within 7 days
old mineralised beads. Thanks to fluorescein isothiocyanate-dextran
molecules with various molecular weights (10, 70 and 250 kDa), it
was possible to determine whether these molecules can enter or not
into the beads, the same experiment was performed with latex beads
of 30 nm to test higher diameter. According to the equation of
Stokes [48], the three dextran-FITC of 10 kDa, 70 kDa and
250 kDa have a diameter of 4, 12 and 22 nm respectively, where
latex beads have a diameter of 30 nm. These products were chosen
because they do not present significant adsorption on silica and
alginate. The Figure 7 shows the results obtained over 7 days. In the
case of small molecules, the bead permeability was large enough to
allow a rapid diffusion of the Dextran-FITC 10 kDa within the
hybrid material. After 3 days, the diffusion equilibrium was reached.
The tendency was the same for the polymers characterized by a
molecular weight of 70 kDa and 250 kDa. Nevertheless, these
bigger molecules diffused less rapidly as proved by the gentler slope
(Figure 7). Larger diameter probes, latex beads carboxylate-
modified of 30 nm, where then used. In this case, there was no
decrease of the fluorescent supernatant. All the latex beads stayed
outside the mineralised beads (experiments were also performed
with latex beads of 500 nm and 1000 nm, with the same
observation – data not shown). Consequently, we assume that the
pore size diameter of our materials is between 22 and 30 nm, as
required for immuno-isolation.
Metabolic activity and cell viability
Several characterisation methods were used to monitor the
survival of cells entrapped within alginate capsules or hybrid
Table 1. Conditions tested to perform the in vitro immune
response test. Determination of IL-8 released in the
supernatant, synonym of a proinflammatory response.
Conditions
Without THP-1 (Fig. 2a) With THP-1 (Fig. 2b)
CH Control HepG2 H HepG2 THP-1
CA Control Alginate A Alginate THP-1
CHA Control Alg+HepG2 AH Alg+HepG2 THP-1
C Control RPMI Medium M THP-1
CS Control Silica S Silica THP-1
CHS Control Silica+HepG2 SH Silica+HepG2 THP-1
doi:10.1371/journal.pone.0020983.t001
Figure 3. Nitrogen adsorption-desorption isotherms. Isotherms
obtained by analysis of purified alginate capsules (a) and mineralised
beads (b).
doi:10.1371/journal.pone.0020983.g003
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beads. The physiological functions of HepG2 cells were firstly
determined by measuring their respiration activity. The consump-
tion rate of oxygen reflects directly the number of active cells.
Results are shown in Figure 8. In purified alginate capsules, the
oxygen consumption slightly increased over one month (Figure 8a).
This observation indicates that the survival rate of entrapped cells
was high. Nonetheless, the respiratory activity decreased after 30
days post-encapsulation. In fact, these results can be explained by
the swelling behaviour and brittleness of alginate capsules. As
highlighted in Figure 4b, the porosity of the alginate crust can
reach 50 mm. Compared to the cell size (8 mm), these holes are
large enough to allow cells to go out of the material. Consequently,
the cellular density confined within the capsules analysed by
oxymetry decreased as function of time. In the case of cells
entrapped within mineralised beads, oxygen consumption sharply
increased during the early stages following the immobilisation step
(,220%) probably due to cell proliferation. As already highlighted
by Figure 4d and Figure 7, Figure 8b shows that HepG2 cells
cannot leave the mineralised beads thanks to the adequate porosity
of these beads. Then, the oxygen consumption remained constant
during more than 42 days. This promising result also suggests that
the encapsulation and the mineralisation processes are totally
benign for sensitive mammalian cells.
In order to confirm these data, cell viability was assessed by
fluorescence microscopy after staining entrapped HepG2 cells with
a commercially available fluorophore (FDA). If cells are still alive,
they exhibit a green fluorescence due to the presence of fluorescein
produced via the hydrolysis of FDA by intracellular esterase.
Figure 9 shows representative micrographs of the hybrid beads
taken in brightfield and fluorescent modes. One hour after
encapsulation, 90% of cells, homogenously dispersed within the
beads, were alive in the matrix as shown in Figure 9a and b. Forty-
two days later, cells were still alive (Figure 9c and d). They were
spread in a carpet-like fashion within the beads. Owing to the
rigidity of hybrid alginate-silica beads, cells cannot divide and
grow as they would without any constraints in culture flask.
HepG2 could be able to divide one or two times as suggested by
the oxygen consumption graph (Figure 9b) and by the optical
Figure 4. Scanning electron microscopy images of (a, b) purified alginate capsules and (c, d) mineralised beads. The materials were
kept during 50 days in the culture medium and supercritically dried with carbon dioxide.
doi:10.1371/journal.pone.0020983.g004
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micrograph (Figure 9c). However, the growth of the daughter cells
would be greatly restricted by the cages that are created around
them during the silica polymerisation. Indeed, the oxygen
consumption rate of each bead did not gradually increase as a
function of time. This is very promising results. In fact, the
preservation of the mitotic activity of cells is not the first goal to
target some kinds of medical applications. For instance, the
synthesis of a ‘‘bioartificial pancreas’’ is based on the encapsulation
of non-dividing cells, namely the beta-cells.
Finally, the efficiency of the immobilisation method was
validated by the human albumin produced and released in the
supernatant by the entrapped HepG2 cells. Twice a week,
supernatants were retrieved and replaced by fresh medium. The
Figure 10 shows albumin concentration daily secreted into the
supernatant. These data show that large molecules (like proteins)
can diffuse through the mineralised beads, while cells remain
confined within the material during a long period of time.
Conclusions
HepG2 cells, selected as a cell model for secreting cells, were
encapsulated into hybrid alginate-silica beads. This work demon-
strates that whole alginate capsules can be completely and
homogenously mineralised by silica. Moreover, the deposition of
aqueous silica species throughout the capsules greatly improves
their long-term mechanical performance. The material precursors
(sodium alginate and sodium silicate) used to construct the beads
are fully biocompatible as indicated by the LDH assay and by the
in vitro immune test (IL-8). After the encapsulation step, more than
90% of cells were kept alive.
The biological activity of entrapped cells was perfectly
preserved during more than 45 days as shown by the respiration
activity and the secretion of albumin. Direct observations of
mineralised bead by fluorescent microscopy suggest that cells
were able to divide once post-immobilisation. Besides, the hybrid
beads are porous, allow the diffusion of nutrients and metabolites
through it and meet the requirements for successful immuno-
isolation with a pore size diameter beneath 30 nm. Such highly
biocompatible hybrid systems with long-term survival could
contribute towards the creation of an ‘‘artificial organ’’ to treat
human disorders. Further works are currently being carried out
on in vivo studies to study the efficiency of the present hybrid
material on animals. In the future, such kind of smart materials
could be used to develop a novel organ substitution technology.
Particularly, the synthesis method developed in this work could
be used to entrap beta-cells in order to design a new treatment for
the Diabetes mellitus.
Figure 5. SEM micrographs (a, b, c) and EDX spectrum (d) of a cross section of a mineralised bead. The bead was conserved in vitro in
the biological medium during one month.
doi:10.1371/journal.pone.0020983.g005
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Figure 6. Microscopy images of an alginate capsule and a mineralized bead showing the silification. Brightfield (a, c, e) and fluorescent
microscopy images (b, d, f) of an alginate capsule (a–b) and a mineralised bead (c–f) in the presence of PDMPO (silica tracer). Micrographs (a–d) and
(e–f) correspond to representative cross sections of the materials and to a whole bead, respectively.
doi:10.1371/journal.pone.0020983.g006
Hybrid Shell for Clinical Applications
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Materials and Methods
Chemical Materials
Ethanol (99.5%, anhydrous), methanol (99.8%), D-sorbitol
(99.5%), sodium chloride (99.5%), calcium chloride (dihydrate,
99%), EGTA (99%), sodium alginate powder (sodium salt from
brown algae), silica nanopowder (99.5%, 5–15 nm), fluorescein
isothiocyanate Dextran (Dextran-FITC) and latex beads carbox-
ylate-modified (L5155) were provided by Sigma-Aldrich; and
glycerol (p.a.), sodium silicate (assay 25.5–28.5% SiO2) by Merck.
The Dubelcco’s Modified Eagle Medium (DMEM), the Roswell
Park Memorial Institute Medium (RPMI) and the foetal bovine
serum were purchased from Invitrogen (Carsbald, USA). Before
used, sodium alginate powder was purified according to the
method described by de Vos et al. [43]. Briefly, this anionic
polysaccharide was dissolved in an aqueous solution of EGTA
1 mM. The insoluble part of the crude commercial mixture was
removed through successive filtrations (from 5 to 0.45 mm). The
alginate fraction was then precipitated via the addition of HCl
2 M at 4uC. The resulting gel was successively washed with HCl
0.01 M, chloroform and butanol. A clear solution was then
recovered by raising the pH to 7.0 (NaOH 0.5 M). Finally the
purified alginate was precipitated via the addition of absolute
ethanol and freeze-dried.
Biological Materials
HepG2 cells (Hepatocellular Liver Carcinoma Cell line) were
cultivated in Dubelcco’s Modified Eagle Medium (DMEM)
supplemented with 10% of foetal bovine serum in 75-cm2
polystyrene flasks (Costar, Lowell, USA). The cells were incubated
at 37uC (95% air/ 5% CO2). After three days of cultivation, cells
were washed with PBS (Phosphate Buffer Saline) and treated with
a trypsin/EDTA cocktail. Trypsinised cells were then centrifuged
and collected in fresh medium with serum either for cultivation or
future encapsulation.
Synthesis of living hybrid microcapsules
This section presents two different routes to encapsulate HepG2
within biocompatible capsules or beads under sterile conditions.
Figure 7. Study of the diffusion of fluorescent probes through 7 days old mineralised beads. 100% corresponds to the fluorescence
intensity of the solution before the addition of the beads. The MWCO is estimated thanks to the hydrodynamic radius of biopolymer: 2, 6 and 11 nm
for the dextran-FITC, and with latex beads carboxylated-modified characterized by a diameter of 30 nm.
doi:10.1371/journal.pone.0020983.g007
Figure 8. Comparison of oxygen consumption at HepG2 cells
encapsulated within (a) alginate capsule or (b) mineralised
bead. 100% corresponds to the oxygen consumption of cells
entrapped within one bead (1.8 102 mmole of O2 hour
21 bead21).
Results are presented as means 6 1 S.D. (n = 3).
doi:10.1371/journal.pone.0020983.g008
Hybrid Shell for Clinical Applications
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Method A. Polymeric capsules were prepared by extruding a
cell suspension (1.5 106 cells ml21) containing 1.0% of purified
sodium alginate into a calcium chloride solution (110 mM). The
presence of Ca2+ cations act as cross-linkers between carboxylate
functions of polysaccharide chains. Since the incubation time of
the drops within the calcium chloride solution was quite short
(5 min), the gelation process only occured in the outer part of the
drops, establishing a solid crust. The capsules were then recovered
and 4 of them were put in test tubes filled with culture medium
with serum and maintained in CO2 incubation in the same
conditions than for routine culture.
Method B. Mineralised beads were achieved according to the
procedure described in Figure 11. Firstly, cells in their buffered
culture medium (pH 7.4) were pre-encapsulated with Ca-alginate
(1.6% wt). The final cell density was 1.5 106 cells ml21. The newly
formed alginate spheres were added to a diluted sodium silicate
solution (1.5 M) for around 30 seconds. A white colour appeared
on their surface, and they were collected. Additional external
alginate layer was formed by re-suspending the beads in 1.5%
sodium alginate solution for 3 min. The outer layer was gelled by
the addition CaCl2 solution (110 mM).
Characterization techniques
Cytotoxicity test. All cells contain the cytosolic enzyme called
LDH (Lactate dehydrogenase). This latter is only located in the
cytoplasm. When cells are dying, the plasma membrane becomes
permeable and cytosolic components go out (e.g. LDH). A
cytotoxicity test can thus be performed by measuring the LDH
released in the supernatant. LDH was quantified in samples using the
‘‘Cytotoxicity Detection KitPLUS’’ from Roche Applied Science
Laboratory. Briefly, 50,000 cells were seeded in a 24-wells plate. After
24 hours of incubation, potentially toxic chemicals were added to
each well. After five hours of incubation, the supernatant of each well
was collected. The HepG2 cells, still attached to the bottom of the
wells, were then lysed by Triton X-100 (10%) in order to recover the
intracellular LDH of intact cells. The extracellular and intracellular
LDH activity was then obtained by measuring the absorbance of
samples at 490 nm according to the manufacturer’s instructions.
Figure 9. Microscopy images highlighting the survival of cells 6 weeks after immobilisation. Brightfield (a, c) and fluorescent microscopy
images (b, d) of HepG2 cells three-dimensionally entrapped within a mineralised bead and labelled with fluorescein diacetate (viability probe). The
micrographs were taken 1 day (a, b) and 42 days (c, d) post-encapsulation.
doi:10.1371/journal.pone.0020983.g009
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Biocompatibility – Immune test
Monocytes THP-1 were used to investigate the biocompatibility
of the capsule. THP-1 cells secrete IL-8 (Interleukin, a primary
inflammatory cytokine) in response to proinflammatory stimuli
(e.g. stress, viruses, lethal compounds) in their environment. In this
case, monocytes THP-1 (commonly used immune defenders for in
vitro experimentations [49–51]) where employed to quantify their
proinflammatory response when they are in contact with the
components of the hybrid beads. In other words, the amount of
IL-8 in the supernatant is an indirect indicator of the
biocompatibility of the materials. Briefly, THP-1 cells were
cultured in serum-free RPMI medium, for 24 h at 37uC before
experimentation to prevent any interference with serum factors.
The day after, cells were washed, re-suspended in complete
medium and then stimulated with our materials. After 24 h of
incubation at 37uC in an atmosphere of 5% CO2, the samples
were centrifuged at 1000 rpm. for 5 min. The supernatants were
collected and stored at 218uC. The IL-8 concentration was
assayed by an ELISA test ‘‘QuantikineH Human CXCL8/IL-8
Immunoassay’’ developed by R&D Systems, Inc., according to the
manufacturer’s protocol.
Material properties
Beads were characterised by fluorescence microscopy in order
to investigate the efficiency of the silicification process. Mineralised
beads and alginate capsules were washed with the culture medium
and then mixed with 20 ml of 2-(4-pyridyl)-5-((4-(2-dimethylami-
nocarbamoyl)methoxy)-phenyl)oxazole (PDMPO, 10 mM). After
5 min. of incubation, beads were observed with a fluorescent
Multizoom AZ100 microscope system (Nikon). Micrographs were
taken at 447/60 nm with a colour camera (DSRi1, Nikon) by
illuminating the samples with a 377/50 nm excitation light. In the
presence of silica, the unique PDMPO-silica interactions induce an
intense blue fluorescence of the material [45].
Morphological and textural properties of alginate capsules and
hybrid beads were collected using aerogels obtained from the
hydrated materials. For that purpose, the capsules and beads were
dehydrated with ethanol, dried through a process of critical point
drying with liquid carbon dioxide and degassed at 70 milliTorrs
overnight at room temperature prior to the measurements.
Specific surface area were calculated using the Brunauer-Emett-
Teller (B.E.T.) equation in the low pressure region (P/P0 between
0,05 and 0,25) [52]. N2 adsorption-desorption experiment was
performed at 2196uC with a volumetric adsorption analyser,
Micromeritics Tristar 3000. Capsule and bead morphology were
examined by field emission scanning electron microscopy (FE-
SEM) on a JEOL JSM-7500F electron microscope with aerogel
sputter-coated with gold. The chemical composition of the samples
was characterised by an energy-dispersion X-rays analysis system
using an acceleration potential of 15 kV, and a working distance of
8 mm.
Molecular weight cut-off (MWCO) and accessible porosity of
the mineralised beads were determined using fluorescent probes
with various hydrodynamic diameters: Dextran-FITC and latex
beads carboxylate-modified. Their diffusion gives information
about the immuno-isolation provided by the mineralised beads.
Briefly, 350 beads (corresponding to 3.0 ml) were synthesized and
aged during 1 week, then mixed with a phosphate buffered
solution (6.0 ml, pH=7.4) containing either 0.4 mg.l21 of dextran
(10, 70 or 250 kDa) labelled by fluorescein isothiocyanate or
200 ml of green fluorescent latex beads carboxylate-modified
(2.5% solids). The changes in the concentration of each substance
were monitored at room temperature as a function of time. The
experiments were performed during several days and the
fluorescence intensity of the probes was recorded with a LS45
Luminescence Spectrometer built by Perkin Elmer: Dextran-FITC
(Excitation wavelength= 494 nm, emission= 518 nm), Latex
beads (Excitation wavelength= 470 nm, emission= 515 nm).
Metabolic activity and cell viability
Firstly, the metabolic functions were assessed by monitoring the
oxygen consumption in a Clark’s cell vessel manufactured by
HansaTech. Typically, four beads were added to the culture
medium (0.8 ml). The respiration activity of entrapped HepG2
cells was measured just after encapsulation and taken as the
reference value (100%), and then over the whole experiment for
the next samples.
Secondly, the cell viability was confirmed with a vital dye
staining (fluorescein diacetate, FDA). Entrapped cells were
Figure 11. Steps for microencapsulation of animal cells into hybrid alginate-silica beads. Cells in suspension are pre-encapsulated in Ca-
alginate capsules and transferred in a diluted sodium silicate solution. The beads are finally coated with a Ca-alginate layer.
doi:10.1371/journal.pone.0020983.g011
Figure 10. Amount of human albumin secreted by HepG2 cells
in the supernatant of the mineralised beads. Concentrations
showed the daily albumin released outside of the hybrid alginate-silica
material as means 6 1 S.D. (n = 3).
doi:10.1371/journal.pone.0020983.g010
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incubated within the culture medium supplement with FDA
(5 mM) at room temperature for 5 minutes. Micrographs were
collected at 536/40 nm with a colour camera (DSRi1, Nikon) by
illuminating the samples with a 482/35 nm excitation light using a
fluorescent microscope (Multizoom AZ100 microscope purchased
from Nikon).
Thirdly, albumin protein secretion by entrapped cells was
monitored over time. Every three or four days, the supernatant
was collected and replaced by fresh culture medium. Thanks to the
‘‘Human Albumin ELISA Kit’’ developed by AssayPro, the
concentration of human albumin was measured and standardised
to obtain its daily production outside of the beads.
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